LEAD Coalition renews call for Congress to boost FY 2025 dementia funding

Today, 383 LEAD Coalition member organizations and allies sent a joint letter urging Congress to continue to prioritize investments to address Alzheimer’s disease and related disorders (AD/ADRD) through dementia-focused FY 2025 appropriations. The letter calls for the FY 2025 appropriations bills to include substantial increases in funding to strengthen the national response to AD/ADRD and […]

LEAD Coalition Supports Passage of the CHANGE Act

On September 27, 288 LEAD Coalition member organizations and allies wrote to Congress in support of the Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act (S.2379 / H.R.4752). The CHANGE Act will strengthen dementia detection and diagnosis, in turn catalyzing improved care, helping promote health equity, and accelerating science to prevent, effectively treat and eventually cure Alzheimer’s […]